Related by context. All words. (Click for frequent words.) 69 dose dependently 67 mechanical allodynia 66 IL 1ß 66 peptide CGRP 66 LPS induced 66 murine model 65 dopamine reuptake 65 adrenoceptor 65 airway hyper responsiveness 65 hyperalgesia 64 glucuronide 64 experimentally induced 64 factor TNF 64 N methyl 64 antiandrogens 64 TNFalpha 64 potentiation 64 vapreotide acetate 64 Interferon alpha 64 5 HT1A receptor 64 selective modulator 63 isoproterenol 63 selective antagonist 63 2A receptor agonist 63 5 hydroxytryptamine 63 interleukin IL -6 63 5HT 63 pathophysiological effects 63 immunostimulatory 63 paricalcitol 63 receptor blocker 63 mecamylamine 63 NMDA antagonist 63 5 HT1A 63 vasoconstrictor 63 selectively inhibits 63 allergic airway inflammation 62 #HT#A 62 salmeterol fluticasone 62 ERK phosphorylation 62 ERalpha 62 cis retinoic acid 62 mineralocorticoid 62 mu opioid 62 M1 muscarinic 62 GHRH 62 humoral antibody 62 nephrotoxicity 62 calcitonin gene related 62 TNF α 62 vasodilatation 62 N acetyl 62 elastase 62 receptor antagonists 62 IFN γ 62 prucalopride 62 alkylating agent 62 VEGF receptor 61 vWF 61 partial agonist 61 serum cortisol 61 deoxy 61 fluticasone furoate 61 zoledronate 61 nociceptive 61 alpha TNF 61 receptor inhibitor 61 erythropoietic 61 inducible nitric oxide synthase 61 selective agonist 61 beta adrenergic 61 desvenlafaxine succinate 61 5 HT3 receptor 61 EUFLEXXA R 61 PEGylated Fab fragment 61 β blockers 61 vecuronium 61 prostaglandin E1 61 IFN α 61 Traficet EN 61 cyclooxygenase 60 ritonavir boosted 60 primidone 60 interleukin IL 60 NMDA receptor antagonist 60 receptor blockers 60 antiandrogen 60 interleukin IL -# 60 steroid dexamethasone 60 leukotriene 60 TNF IL 60 adenosine diphosphate ADP 60 adenylate cyclase 60 busulfan 60 DFMO 60 E selectin 60 antiinflammatory 60 caspofungin 60 serotonin reuptake inhibitor 60 inverse agonist 60 Th2 cytokines 60 receptor agonists 60 db db mice 60 pentoxifylline 60 5alpha 60 Overexpression 60 receptor subtypes 60 agonism 60 conventional DMARDs 60 interferon γ 60 prostaglandin E2 PGE2 60 hypothalamic pituitary 60 adrenergic receptors 60 locomotor activity 60 ligand TRAIL 60 nanomolar 60 nicotinic 60 tricyclic 60 Angiotensin II 60 LNCaP cells 60 CorVue ™ 59 ACh 59 mitogenic 59 microglial activation 59 hydroxylase 59 doxorubicin cyclophosphamide 59 prostanoid 59 noradrenergic 59 HT 1A 59 SGPT 59 antisense inhibition 59 alpha2 59 uM 59 PD L1 59 somatostatin analog 59 tolterodine ER 59 Antitumor 59 enkephalin 59 5 HT6 receptor 59 fluticasone salmeterol 59 endothelin receptor 59 antiapoptotic 59 muscarinic receptor 59 cytoprotective 59 NS#/#A protease 59 saline placebo 59 p# mitogen activated 59 ERK1 2 59 D aspartate NMDA receptor 59 5 HT2A receptor 59 pyridostigmine 59 nadolol 59 Omacetaxine mepesuccinate 59 5alpha reductase 59 protein tyrosine phosphatase 1B 59 sodium glucose cotransporter 59 6 OHDA 59 endotoxemia 59 prostaglandin E 59 azacytidine 59 glutamyl 59 receptor subtype 59 proinflammatory cytokine 59 inhibitory effects 59 zonisamide SR 59 NMDA antagonists 59 bicalutamide 59 verteporfin 59 Nebulized 59 immunomodulatory effects 59 mg TID 59 cardioprotection 59 receptor partial agonist 59 polymyxin B 59 tumor necrosis 59 IL6 59 dopamine D2 59 hepatic enzymes 58 opioid receptor antagonist 58 viral titers 58 Kinoid 58 BoNT 58 #ß 58 Selective Inhibitor 58 amikacin 58 PDGF BB 58 adipogenic 58 ,#,# [002] 58 effector function 58 liposome formulation 58 Interferon gamma 58 agonists antagonists 58 Intrathecal 58 Th1 cells 58 GI motility 58 AT1 receptor 58 antitumor efficacy 58 Natalizumab 58 ouabain 58 CGRP 58 CorVue TM 58 antiemetics 58 selective adenosine 58 cefotaxime 58 Cyclosporine 58 catabolism 58 ischemia induced 58 adenylyl cyclase 58 antifibrotic 58 cannabinoid receptor 58 ^ sup #m 58 pyrimidines 58 steroidogenic 58 PPARgamma 58 avidin 58 L lysine 58 serotonin reuptake 58 fibrin deposition 58 fluticasone propionate FP 58 cytokines IL 58 intradermal injection 58 antidepressant efficacy 58 fosbretabulin 58 IL #p# 58 H2RAs 58 gonadotropin releasing hormone GnRH 58 IGFBP 3 58 alpha 2A 58 mitochondrial biogenesis 58 aspartate aminotransferase 58 muscarinic receptors 58 selectively inhibited 58 intramuscularly 58 receptor agonist 58 receptor kinase 58 piperacillin tazobactam 58 plasmid encoding 58 μg ml 58 ALB # 58 analgesic efficacy 58 intermittent hypoxia 58 GH secretion 58 methyl D aspartate 58 antiproliferative effects 58 abacavir lamivudine 58 corticosteroid therapy 58 constitutively active 58 gastrointestinal motility 58 TNF inhibitor 58 laropiprant 57 Î ² 57 liposomal formulation 57 imipramine 57 oral prodrug 57 TNFα 57 imatinib Gleevec 57 hepatotoxic 57 hyperresponsiveness 57 cytotoxic T lymphocyte 57 PEG IFN 57 antitrypsin 57 vitro cytotoxicity 57 mcg BID 57 IFN g 57 FasL 57 HMG CoA reductase inhibitors 57 beta 1a 57 Bone Morphogenetic Protein 57 nM 57 peroxisome proliferator activated 57 adrenocortical 57 ischemia reperfusion 57 GlcNAc 57 TLR2 57 leukocyte infiltration 57 NMES 57 nmol 57 cytokine IL 57 inhibitory effect 57 vasoactive 57 detrusor 57 PDE4 inhibitors 57 thrombin receptor 57 reversible inhibitor 57 #mg/day [002] 57 nitric oxide synthase NOS 57 Tumor necrosis factor 57 Reductase 57 IFN alpha 57 pathway inhibitor 57 adrenergic 57 CIMZIA TM 57 Vasopressin 57 denervation 57 budesonide formoterol 57 APTIVUS r 57 cytokine signaling 57 VAPRISOL 57 PKC inhibitor 57 PTHrP 57 PPAR gamma agonists 57 inflammatory cytokines TNF 57 PKC inhibitors 57 μg kg 57 ropivacaine 57 highly selective endothelin 57 MGd 57 nephrotoxic 57 Akt activation 57 coadministration 57 isoprostane 57 erythropoiesis 57 FK# 57 mTOR inhibitors 57 type glutamate receptor 57 tryptase 57 phosphate S1P 57 intratumoral 57 5 HT2A 57 HPA axis 57 cyclic nucleotide 57 hyperoxia 57 pamidronate 57 NR2B selective 57 antidiabetic 57 nicotinamide 57 5 lipoxygenase 57 EGFR antibodies 57 gastric acid secretion 57 LHRH agonist 57 ornithine 57 cinacalcet 57 systemic bioavailability 57 amprenavir 57 neutralizing antibody responses 57 dual endothelin receptor antagonist 57 Angiotensin 57 carcinoembryonic antigen 57 bronchodilation 57 isoenzymes 57 CIMZIA R 57 eplerenone 57 acetylcholine receptor 57 ob ob mice 57 myocardial reperfusion 57 1α 57 oxycodone CR 57 Decitabine 57 intraperitoneal injection 57 transgene expression 57 glucocorticoid receptors 57 intra articular injection 57 sotalol 56 injected subcutaneously 56 5 HT2C receptor 56 gonadotropin releasing hormone 56 malondialdehyde 56 adrenoceptor agonist 56 immunomodulatory 56 antithymocyte globulin 56 Pegylated Liposomal Doxorubicin 56 nucleoside analogs 56 tau phosphorylation 56 Adjunctive 56 VEGF inhibitors 56 Annexin V 56 trastuzumab Herceptin ® 56 NKG2D 56 Angiotensin converting enzyme 56 phosphodiesterase inhibitors 56 AT1R 56 NF kappaB activation 56 haematologic 56 mdx mice 56 Durezol 56 Leukotriene 56 inflammatory cytokine 56 chloride secretion 56 Prostaglandin 56 ^ sup ^ 56 HuR 56 lanreotide 56 parthenolide 56 Sulfonylurea 56 mediated inhibition 56 Double Blind Randomized 56 kallikrein 56 thyrotropin 56 QbG# 56 morphometric vertebral fractures 56 factor Xa 56 pilocarpine 56 LH RH 56 mu opioid receptor 56 osteoclastic 56 receptor PPAR 56 HER2 overexpression 56 chemokine receptor 56 insulin sensitizing 56 μM 56 alpha adrenergic 56 reuptake inhibitors 56 ACTH 56 sodium nitroprusside 56 induced cytotoxicity 56 hypothalamic pituitary adrenal axis 56 lipoxygenase 56 daily subcutaneous injections 56 antiarrhythmic drug 56 non steroidal 56 hematologic toxicity 56 lytic 56 parathyroid hormone PTH 56 guanfacine extended release 56 cerebral ischemia 56 CCR2 56 rFVIIa 56 partial agonists 56 hydroxypropyl 56 ERK activation 56 subcutaneously administered 56 ketorolac 56 ALT normalization 56 nicardipine 56 8mg/kg 56 CHOP chemotherapy 56 Interferon alfa 56 rhTSH 56 pegylated 56 Caveolin 1 56 sufentanil 56 metabolizing enzyme 56 isoenzyme 56 equimolar 56 cAMP signaling 56 bronchodilatory 56 lactate dehydrogenase 56 dioxygenase 56 synthetic analogues 56 homolog 56 sub maximal 56 topically administered 56 platelet activation 56 oral rivaroxaban 56 Capesaris 56 ZFP TF 56 Janus kinase 56 transdermal estradiol 56 remifentanil 56 HCV replicon 56 Butyrate 56 adrenergic receptor 56 Ranolazine 56 glycosyltransferase 56 L methionine 56 opioid antagonist 56 related apoptosis inducing 56 AChE 56 muscarinic 56 antitumor effect 56 idarubicin 56 methacholine 56 Beta catenin pathway 56 C#BL/#J 56 mGluR5 antagonist 56 ara C 56 norepinephrine reuptake inhibition 56 receptor antagonist 56 adenosine receptor 56 homozygotes 56 plasma pharmacokinetics 56 aspartate 56 LPA1 receptor 56 Aldosterone 56 IAP inhibitor 56 CXCL# 56 mg kg dose 56 potent antiproliferative 56 Fenretinide 56 eotaxin 56 plasminogen activator 56 serum IgG 56 Plasma concentrations 55 Valproic acid 55 irbesartan 55 racemic 55 bexarotene 55 angiotensin receptor 55 contractility 55 acyltransferase 55 mucociliary clearance 55 mesalazine 55 anti inflammatory cytokine 55 inotropic 55 adjunctive placebo 55 PEGylated interferon 55 Neuropeptide Y 55 vidofludimus 55 Non inferiority 55 nmol liter 55 cytokine receptor 55 aminotransferases 55 Preclinical studies indicate 55 lumbar spine BMD 55 #mg BID [001] 55 IFN beta 55 long acting muscarinic 55 aspartate aminotransferase AST 55 mitogen activated protein kinase 55 acromegalic patients 55 urinary N telopeptide 55 tapentadol ER 55 micafungin 55 endogenous opioid 55 anti fibrotic 55 colorectal adenoma 55 alanine aminotransferase ALT 55 RANK Ligand 55 antisense compounds 55 proteasome inhibitors 55 rhGH 55 endothelium dependent 55 TIMP 1 55 CTLs 55 bone morphogenetic proteins BMPs 55 dehydrogenase 55 microsomes 55 CORT # 55 retinoic acid receptor 55 mimetic peptide 55 postprandial glycemia 55 #mg BID [003] 55 enzyme inhibition 55 cannabinor 55 ACE inhibitor ramipril 55 reuptake inhibition 55 potent inhibitors 55 nicotinic acetylcholine receptor 55 echinocandins 55 serotonin receptor 55 androgen suppression 55 Th2 responses 55 iloprost 55 neurokinin 1 55 corticosteroid dexamethasone 55 dosing frequency 55 platelet inhibition 55 enzyme inhibitors 55 NK1 55 administered intranasally 55 plasma cortisol 55 agonist 55 mol L 55 K ras mutations 55 thyroid hormone receptor 55 pigment epithelium derived 55 hyperinsulinemic euglycemic clamp 55 phenelzine 55 GnRH agonist 55 nutlin 3a 55 fig. S2 55 μmol L 55 ug kg 55 microglial 55 vasodilator 55 mcg ml 55 Lovaza ® 55 PTP 1B 55 rFSH 55 agonists 55 alpha agonists 55 tumorigenicity 55 L PPDS 55 plasma uric acid 55 #ME# 55 GABRA2 55 systemic corticosteroid 55 Protelos 55 INVEGA ® 55 pharmacokinetic profiles 55 recurrent glioblastoma multiforme 55 histone deacetylase inhibitors 55 glucagon receptor 55 metabolic parameters 55 neointimal hyperplasia 55 secretase 55 serum urate 55 phospholipase 55 fractional shortening 55 analgesic effects 55 opioid analgesia 55 dopamine D1 55 antiarrhythmic 55 transcranial 55 F FDG PET 55 intravitreal injections 55 P selectin 55 t# c# CLA 55 selectively inhibit 55 SGS# 55 microsomal 55 macrophage colony stimulating 55 prodrugs 55 urate lowering therapy 55 selective antagonists 55 NMDA N 55 alkaline phosphatase ALP 55 hepatic fibrosis 55 transferase 55 XP# Transported Prodrug 55 CLA supplementation 55 budesonide pMDI 55 cytotoxic effects 55 percutaneous tibial nerve 55 aminobutyric acid 55 negative allosteric modulator 55 estramustine 55 #HT# 55 cytochrome 55 opioid agonists 55 oral levofloxacin 55 antitumoral 55 Androgen receptor 55 malate 55 neovascular 55 catecholamine 55 electro acupuncture 54 HIF 1alpha 54 4mg/kg 54 epoetin beta 54 FOLFOX6 54 radiographic progression 54 leukocytosis 54 AUC0 54 baroreceptor 54 inhibitor RG# 54 CC genotype 54 QT QTc 54 liposomal doxorubicin 54 estrogen receptor beta 54 tacrolimus ointment 54 Alanine 54 K#R [002] 54 bronchial hyperresponsiveness 54 serine proteases 54 antiangiogenic 54 hepatic glucose production 54 hematological parameters 54 CCR7 54 HIF 1a 54 anti angiogenic agent 54 glutamate receptors 54 pyrazinamide 54 COX2 54 triglycerides TG 54 MAGE A3 ASCI 54 LANTUS R 54 autoantibody levels 54 vagal 54 gB 54 HIF PH inhibitors 54 CD#b 54 Gliclazide 54 apoptosis induced 54 eIF4E 54 radiolabeled monoclonal antibody 54 proteasome inhibitor 54 virological response 54 c MYC 54 5 HT4 receptor 54 paroxysmal AF 54 ibandronate 54 serine protease inhibitor 54 Darusentan 54 lispro 54 R baclofen 54 timepoints 54 5 HT2B receptor 54 anticancer activity 54 cytostatic 54 SAMe 54 dopamine norepinephrine 54 EP3 receptor 54 urinary excretion 54 plasma renin activity 54 Vps# 54 TGF beta signaling 54 GLP1 agonist 54 Galectin 54 Pharmacokinetic parameters 54 synovial cells 54 androgen receptor AR 54 KLF4 54 PI3K/mTOR 54 neuroprotective properties 54 pDCs 54 timolol maleate 54 microvessel density 54 osteoblast activity 54 ABC/3TC 54 hour bronchodilation 54 cytotoxin 54 prostacyclins 54 TLR9 mediated immune 54 teriflunomide 54 phosphatases 54 improves glycemic 54 Preclinical studies suggest 54 nucleoside analogues 54 QTc intervals 54 C#BL 6 mice 54 PaO 2 54 vasodilating 54 nitroprusside 54 dual orexin receptor 54 μg mL 54 IGF IR 54 adrenal suppression 54 lenalidomide dexamethasone 54 pulmonary arterial 54 bazedoxifene selective estrogen receptor 54 pharmacodynamic parameters 54 Hypoxia Inducible Factor 54 thrombopoietin 54 bradykinin 54 Hypotension 54 receiving VICTRELIS 54 hepatic insulin sensitivity 54 striatal dopamine 54 enzyme inhibitor 54 HIF 1α 54 histone deacetylase 54 Alkaline Phosphatase 54 hemodilution 54 hypoperfusion 54 SIRT2 54 Agonist 54 vasodilators 54 intravascular hemolysis 54 dihydro 54 NTx 54 bioavailable testosterone 54 focally 54 inhibitory receptor 54 IFNs 54 channel ENaC 54 nasal spray formulation 54 beta subunit 54 ergocalciferol 54 renin angiotensin aldosterone 54 annexin 54 ENaC 54 non selective NMDA 54 mineralocorticoid receptor 54 dorzolamide 54 fulvestrant 54 5-FU/LV 54 Y2 receptor 54 thromboxane 54 chimeric monoclonal antibody 54 Tumor Response 54 selective inhibitors 54 CB1 receptor 54 CIMZIA TM certolizumab pegol 54 procainamide 54 bisacodyl 54 serum concentrations 54 N acetylcysteine 54 neutrophil counts 54 statin monotherapy 54 corticosteroid dose 54 procollagen 54 mcg mL 54 degranulation 54 TLR9 54 neuropeptide Y 54 HLA DR4 54 Locked Nucleic Acid LNA 54 antiresorptive 54 losartan Cozaar 54 serum bicarbonate 54 quinolone 54 mesilate 54 GLP1 54 gonadotrophin releasing hormone 53 BENICAR HCT 53 syndrome IBS 53 5 HT4 53 immune stimulatory 53 electrostimulation 53 PPARγ 53 Tumour Necrosis Factor 53 receptor mediated 53 TNF á 53 dose proportionality 53 A2A receptor 53 ACE Inhibitor 53 PI3 kinase 53 #beta estradiol 53 NMDAR 53 lesional 53 KSP inhibitor 53 immunoglobulin Ig 53 MDR1 53 globulin 53 baroreflex 53 costimulatory molecules 53 agonist compounds 53 methacholine challenge 53 agonist LABA 53 CCL2 53 Aptivus ® 53 bromocriptine 53 suppressor cells 53 mitomycin 53 insulin sensitizers 53 cardiac contractility 53 neurokinin 53 HSP# inhibitor 53 5 HT2C 53 coronary stenosis 53 apolipoprotein B 53 Monoamine Oxidase 53 serum urate levels 53 MBq 53 pharmacokinetic parameters 53 T2DM 53 oxime 53 neuropilin 53 propanol 53 AST ALT 53 endothelial activation 53 antibody titers 53 salmeterol inhalation powder 53 hemoglobin Hb 53 Pharmacokinetic Study 53 triiodothyronine 53 generation antisense inhibitor 53 glyceryl 53 antifolates 53 unconjugated 53 vasopressor 53 reperfusion injury 53 interleukin 1ß 53 deoxyglucose 53 alagebrium 53 VEGF receptors 53 hypercapnia 53 cyclin dependent kinase inhibitor 53 GSK3B 53 eosinophil count 53 inhibiting COX 53 methoxy 53 pharmacologic 53 NADPH 53 pressor response 53 T1 weighted images 53 intravenous bolus 53 neomycin 53 TPV r 53 PPAR agonist 53 53 chlorthalidone 53 corifollitropin alfa 53 lactate dehydrogenase LDH 53 vastus lateralis 53 reductase 53 collagen degradation 53 nerve conduction velocity 53 gamma agonists 53 achieved statistical significance 53 resolvins 53 amylin 53 soluble CD# 53 gonadotrophin releasing hormone GnRH 53 inhibin 53 STAT3 signaling 53 knee osteoarthritis OA 53 wildtype 53 BH3 53 Anticalins ® 53 CYT# QbG# 53 protein phosphatase 53 serum HBV DNA 53 antral 53 HT 2A 53 ASTELIN 53 ALT elevations 53 F FLT 53 inhaled corticosteroids ICS 53 mesalamine granules 53 alteplase 53 diuresis 53 costimulation 53 CDKs 53 nitrosothiols 53 mGluR2 NAM 53 melatonin receptor 53 thyroxine T4 53 IFN alfa 53 CXCR2 53 cyclic peptide 53 infarct size 53 ghrelin agonist 53 ischaemia 53 adenosine A2A 53 humoral 53 p = NS 53 galectin 53 Apoptone 53 penicillin G benzathine 53 glucoside 53 beta alanine 53 P#Y# [002] 53 oxytocin receptor 53 glucocorticoid receptor 53 alanine aminotransferase 53 SCIg 53 BMS # 53 urinary oxalate 53 viral titer 53 neuroregenerative 53 p# activation 53 potent inhibitor 53 interferon beta 53 micromolar 53 cefazolin 53 pharmacologic approaches 53 yl 53 relapsed MM 53 mutated K ras 53 pegylated IFN 53 metastatic lymph nodes 52 H. influenzae 52 myogenic 52 inotropic agents 52 hippocampal atrophy 52 CK # administered 52 ABVD 52 pharmacokinetic characteristics 52 intravenous dosing 52 bronchoalveolar lavage 52 chemoradiation therapy 52 acetabular dysplasia 52 ARG# 52 intestinal mucosal 52 PECAM 1 52 inhaled fluticasone 52 effector T 52 metabolite concentrations 52 dosage regimens 52 tumor vasculature 52 delta opioid receptor 52 normoxic 52 FXIII 52 catenin 52 micronuclei 52 cortisol receptor 52 GnRH receptor 52 ovalbumin 52 p ≤ 52 vascular disrupting agents 52 concentration Cmax 52 FDG uptake 52 modulatory 52 FFNS 52 PPARg 52 adrenoreceptor 52 serum homocysteine 52 thromboxane A2 52 Adenosine A2A 52 antagomirs 52 Notch1 52 hyperphenylalaninemia HPA due 52 MyoCell ® 52 capillary density 52 Interferon beta 52 growth hormone secretion 52 PTH secretion 52 mg kg ip 52 secondary efficacy endpoint 52 doxorubicin docetaxel 52 purified protein 52 CTLA 4 52 HPA axis suppression 52 electrophysiologic 52 collagenous colitis 52 PAK1 52 radiotherapy RT 52 Topoisomerase II 52 inverse agonists 52 selective serotonin 2C receptor 52 liposomal amphotericin B 52 pmol 52 membrane permeability 52 capsules USP 52 bupropion SR 52 RAPAFLO R 52 glycolytic